Blog

CRISPR Used to Disable Defective Gene in ALS – Rare Disease Report


Rare Disease Report

CRISPR Used to Disable Defective Gene in ALS
Rare Disease Report
In historical studies, CRISPR/Cas9 technology has exhibited the ability to decrease the functionality of the mutant Dystrophin protein which has long been believed to be the underlying cause of Duchenne muscular dystrophy (DMD). Recent data from

2018-01-04 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.